| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $115.8M | +11.1% | +29.6% |
| R&D Expense | $11.1M | -14.3% | +25.9% |
| SG&A Expense | $29.3M | -19.8% | +17.1% |
| Operating Income | $45.2M | +85.8% | +59.4% |
| Pre-tax Income | $39.9M | +87.5% | +31.9% |
| Income Tax | $9.1M | +95.2% | +62.4% |
| Net Income | $30.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.3M | -94.8% | -83.8% |
| Accounts Receivable | $58.8M | +3.0% | +33.7% |
| Current Assets | $77.3M | -59.2% | -16.6% |
| Total Assets | $439.2M | -19.8% | -3.8% |
| Current Liabilities | $93.9M | +22.9% | +48.2% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $116.8M | — | — |
| Capital Expenditures | $524K | — | — |
| Investing Cash Flow | -$5.7M | — | — |
| Financing Cash Flow | -$163.9M | — | — |
| Free Cash Flow | $116.2M | — | — |
| +85.3% |
| +24.9% |
| EPS (Basic) | $0.16 | +100.0% | +14.3% |
| EPS (Diluted) | $0.16 | +100.0% | +77.8% |
| $279.9M |
| -1.3% |
| -4.8% |
| Total Liabilities | $368.2M | +2.3% | -21.6% |
| Stockholders' Equity | $71.0M | -62.2% | +629.4% |